The goal of the current study was to test the hypothesis that ALDH1 is not simply a marker of highly aggressive breast cancer cells and poor patient prognosis, but that it also contributes functionally to metastatic behavior and therapy resistance. Here, ALDH1A1 is linked to breast cancer.